2-[4-(3-Oxo-3H-[1,2]dithiol-4-yl)-phenoxy]-N-[4-(3-trifluoromethyl-phenylamino)-quinazolin-6-yl]-acetamie

ID: ALA4791589

Chembl Id: CHEMBL4791589

PubChem CID: 162671649

Max Phase: Preclinical

Molecular Formula: C26H17F3N4O3S2

Molecular Weight: 554.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(COc1ccc(-c2cssc2=O)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1

Standard InChI:  InChI=1S/C26H17F3N4O3S2/c27-26(28,29)16-2-1-3-17(10-16)33-24-20-11-18(6-9-22(20)30-14-31-24)32-23(34)12-36-19-7-4-15(5-8-19)21-13-37-38-25(21)35/h1-11,13-14H,12H2,(H,32,34)(H,30,31,33)

Standard InChI Key:  FXWHQHVLSXRKQV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4791589

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Egfr Epidermal growth factor receptor erbB1 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 554.58Molecular Weight (Monoisotopic): 554.0694AlogP: 6.56#Rotatable Bonds: 7
Polar Surface Area: 93.21Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.50CX Basic pKa: 3.98CX LogP: 5.97CX LogD: 5.97
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.22Np Likeness Score: -1.45

References

1. Zheng YG,Zhang WQ,Meng L,Wu XQ,Zhang L,An L,Li CL,Gao CY,Xu L,Liu Y.  (2020)  Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (HS) donors as potent EGFR inhibitors against L858R resistance mutation.,  202  [PMID:32619886] [10.1016/j.ejmech.2020.112522]

Source